Clinical Trial Update: Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164) [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial evaluating a fixed-dose combination of etoricoxib and tizanidine for moderate to severe acute low back pain has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Etoricoxib (Arcoxia) (etoricoxib)
• ZANAFLEX (Tizanidine hydrochloride)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Low Back Pain | Phase 3 | Status: WITHDRAWN